FDA refuses to disclose how it spends industry “user fees” – are funds being secretly used on LOBBYING?

FDA refuses to disclose how it spends industry “user fees” – are funds being secretly used on LOBBYING?

  • March 20, 2024

Ethan Huff, News Target

It is routine for the U.S. Food and Drug Administration (FDA) to collect “user fees” from the industries it regulates to fund testing and regulation of said industries’ products, but is that actually where the money is going?

A new investigation speculates that the FDA might just be spending that user fee cash on something other than what the law stipulates, seeing as how the agency refuses to answer questions about the matter.

Last summer, a Freedom of Information Act (FOIA) request was filed seeking basic information about the agency’s user fee spending habits. When the FDA refused to honor the request, the group Protect the Public’s Trust (PPT) was forced to take the agency to court.

“Remarkably, it took roughly five months for the FDA to wrap their heads around our request,” reported Real Clear Wire’s Michael Chamberlain. “Two months later, we still await the first production of what FDA reports is 1,685 documents that respond to our search criteria.”

“Access to user fee data may be the key to unlocking the agency’s true motivations – and whether prohibitionist special interests, such as those funded by billionaires like Michael Bloomberg, are in fact, the real decision-makers driving the agency’s policy agenda,” Chamberlain writes about the importance of getting to the bottom of this important matter as soon as possible in the interest of public trust.

Read more